Latest Callan Capital, LLC Stock Portfolio
Callan Capital, LLC Performance:
2025 Q1: -1.63%YTD: -1.63%2024: -5.56%
Performance for 2025 Q1 is -1.63%, and YTD is -1.63%, and 2024 is -5.56%.
About Callan Capital, LLC and 13F Hedge Fund Stock Holdings
Callan Capital, LLC is a hedge fund based in LA JOLLA, CA. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.5 Billions. In it's latest 13F Holdings report, Callan Capital, LLC reported an equity portfolio of $1.4 Billions as of 31 Mar, 2025.
The top stock holdings of Callan Capital, LLC are FNDA, META, FNDA. The fund has invested 9.4% of it's portfolio in SCHWAB STRATEGIC TR and 8.1% of portfolio in META PLATFORMS INC.
The fund managers got completely rid off DBX ETF TR (HYRM), DANAHER CORPORATION (DHR) and QIAGEN NV stocks. They significantly reduced their stock positions in SPDR DOW JONES INDL AVERAGE (DIA), STELLANTIS N.V and PFIZER INC (PFE). Callan Capital, LLC opened new stock positions in PRIMO BRANDS CORPORATION, SPDR SER TR (BIL) and TAKEDA PHARMACEUTICAL CO LTD (TAK). The fund showed a lot of confidence in some stocks as they added substantially to ORIX CORP (IX), QUANTUM SI INC (QSI) and ISHARES TR (IJR).
The top stock holdings of Callan Capital, LLC are FNDA, META, FNDA. The fund has invested 9.4% of it's portfolio in SCHWAB STRATEGIC TR and 8.1% of portfolio in META PLATFORMS INC.
The fund managers got completely rid off DBX ETF TR (HYRM), DANAHER CORPORATION (DHR) and QIAGEN NV stocks. They significantly reduced their stock positions in SPDR DOW JONES INDL AVERAGE (DIA), STELLANTIS N.V and PFIZER INC (PFE). Callan Capital, LLC opened new stock positions in PRIMO BRANDS CORPORATION, SPDR SER TR (BIL) and TAKEDA PHARMACEUTICAL CO LTD (TAK). The fund showed a lot of confidence in some stocks as they added substantially to ORIX CORP (IX), QUANTUM SI INC (QSI) and ISHARES TR (IJR).
Callan Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Callan Capital, LLC made a return of -1.63% in the last quarter. In trailing 12 months, it's portfolio return was -9.04%.
New Buys
| Ticker | $ Bought |
|---|---|
| primo brands corporation | 5,167,590 |
| spdr ser tr | 1,231,540 |
| spdr ser tr | 986,678 |
| berkshire hathaway inc del | 798,442 |
| takeda pharmaceutical co ltd | 734,950 |
| vanguard bd index fds | 488,736 |
| spdr ser tr | 387,787 |
| mondelez intl inc | 371,682 |
New stocks bought by Callan Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| orix corp | 496 |
| quantum si inc | 464 |
| ishares tr | 217 |
| vanguard index fds | 180 |
| ishares inc | 152 |
| american intl group inc | 123 |
| dyadic intl inc del | 86.79 |
| sanofi | 81.66 |
Additions to existing portfolio by Callan Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| spdr dow jones indl average | -44.88 |
| stellantis n.v | -43.16 |
| pfizer inc | -36.17 |
| vanguard intl equity index f | -31.68 |
| cgi inc | -25.89 |
| thermo fisher scientific inc | -24.19 |
| vanguard mun bd fds | -23.67 |
| regeneron pharmaceuticals | -16.5 |
Callan Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| redwood trust inc | -163,250 |
| western un co | -138,468 |
| keycorp | -174,777 |
| dbx etf tr | -332,962 |
| equinor asa | -221,691 |
| know labs inc | -63,677 |
| qiagen nv | -284,547 |
| invesco exch traded fd tr ii | -241,250 |
Callan Capital, LLC got rid off the above stocks
Sector Distribution
Callan Capital, LLC has about 77.5% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 77.5 |
| Communication Services | 9.6 |
| Technology | 6.4 |
| Healthcare | 1.5 |
| Consumer Cyclical | 1.4 |
| Financial Services | 1.2 |
Market Cap. Distribution
Callan Capital, LLC has about 22.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 77.5 |
| MEGA-CAP | 17.8 |
| LARGE-CAP | 4.4 |
Stocks belong to which Index?
About 21.8% of the stocks held by Callan Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 78 |
| S&P 500 | 21.8 |
Callan Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Callan Capital, LLC
Callan Capital, LLC has 364 stocks in it's portfolio. About 47.4% of the portfolio is in top 10 stocks. NVDA proved to be the most loss making stock for the portfolio. XLB was the most profitable stock for Callan Capital, LLC last quarter.
Last Reported on: 29 Apr, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AAPL | apple inc | 2.12 | 129,174 | 28,693,300 | reduced | -1.05 | ||
| AAXJ | ishares tr | 0.06 | 11,005 | 868,187 | reduced | -4.35 | ||
| AAXJ | ishares tr | 0.04 | 4,798 | 491,363 | unchanged | 0.00 | ||
| AAXJ | ishares tr | 0.02 | 4,028 | 212,655 | new | |||
| ABBV | abbvie inc | 0.12 | 7,408 | 1,552,220 | added | 21.12 | ||
| ABT | abbott labs | 0.08 | 8,527 | 1,131,110 | added | 17.52 | ||
| ACN | accenture plc ireland | 0.06 | 2,525 | 787,901 | added | 0.72 | ||
| ACWF | ishares tr | 1.71 | 749,022 | 23,099,800 | reduced | -2.67 | ||
| ACWF | ishares tr | 0.03 | 6,480 | 375,069 | added | 0.03 | ||
| ADBE | adobe inc | 0.09 | 2,997 | 1,149,440 | added | 9.3 | ||
| ADI | analog devices inc | 0.04 | 2,690 | 542,492 | added | 13.17 | ||
| ADP | automatic data processing in | 0.01 | 669 | 204,400 | new | |||
| AEMB | american centy etf tr | 2.31 | 448,149 | 31,253,900 | added | 1.05 | ||
| AEMB | american centy etf tr | 1.99 | 307,975 | 26,846,200 | reduced | -2.08 | ||
| AEMB | american centy etf tr | 0.45 | 66,308 | 6,125,570 | reduced | -12.56 | ||
| AEMB | american centy etf tr | 0.20 | 56,044 | 2,643,010 | added | 7.4 | ||
| AEMB | american centy etf tr | 0.12 | 23,770 | 1,550,040 | reduced | -4.45 | ||
| AEMB | american centy etf tr | 0.11 | 26,949 | 1,527,470 | reduced | -1.7 | ||
| AFL | aflac inc | 0.02 | 2,755 | 306,328 | added | 15.85 | ||
| AGNG | global x fds | 0.03 | 13,134 | 373,794 | unchanged | 0.00 | ||